021-51111890
购物车（0）
sales@molnova.cn
TV 3279
CAS No. 209394-29-6
TV 3279 ( —— )
产品货号. M36850 CAS No. 209394-29-6
TV 3279 is a novel ChE-MAI inhibitor , and the neuroprotective properties depend on their ability to induce the anti-apoptotic proteins PKC, Bcl-2, Bcl-x, and SOD, and to block the nuclear translocation of the pro-apoptotic enzyme glyceraldehyde phosphate dehydrogenase in PC-12 and neuroblastoma cells.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2519 | 有现货 |
|
| 5MG | ￥3553 | 有现货 |
|
| 10MG | ￥5233 | 有现货 |
|
| 25MG | ￥7718 | 有现货 |
|
| 50MG | ￥10870 | 有现货 |
|
| 100MG | ￥14306 | 有现货 |
|
| 500MG | ￥28535 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TV 3279
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述TV 3279 is a novel ChE-MAI inhibitor , and the neuroprotective properties depend on their ability to induce the anti-apoptotic proteins PKC, Bcl-2, Bcl-x, and SOD, and to block the nuclear translocation of the pro-apoptotic enzyme glyceraldehyde phosphate dehydrogenase in PC-12 and neuroblastoma cells.
-
产品描述TV 3279 is a novel ChE-MAI inhibitor , and the neuroprotective properties depend on their ability to induce the anti-apoptotic proteins PKC, Bcl-2, Bcl-x, and SOD, and to block the nuclear translocation of the pro-apoptotic enzyme glyceraldehyde phosphate dehydrogenase in PC-12 and neuroblastoma cells.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点PKC
-
受体PKC | BCL
-
研究领域——
-
适应症——
化学信息
-
CAS Number209394-29-6
-
分子量272.34
-
分子式C16H20N2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESN(CC#C)[C@@H]1C=2C(CC1)=CC=C(OC(N(CC)C)=O)C2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
R 59-022 hydrochlori...
R 59-022 (DKGI-I) hydrochloride 是一种 DGK 抑制剂 (IC50: 2.8 μM)。R 59-022 hydrochloride 抑制 OAG 磷酸化为 OAPA。R 59-022 hydrochloride 是一种 5-HT Receptor 拮抗剂，可激活蛋白激酶 C (PKC)。R 59-022 增强血小板中凝血酶诱导的甘油二酯的产生，并抑制嗜中性粒细胞中磷脂酸的产生。
-
Hypocrellin A
Hypocrellin A 是 PKC 抑制剂，具有光诱导的抗肿瘤、抗真菌和抗病毒活性，它还对 MHC 限制性抗原呈递发挥免疫调节作用。
-
Bisindolylmaleimide ...
Bisindolylmaleimide VIII (Ro-31-7549) is a selective and potent protein kinase C (PKC) inhibitor with good inhibition of PKC-α, PKC-β I, PKC-β II, PKC-γ, and PKC-ε.Bisindolylmaleimide VIII Bisindolylmaleimide VIII inhibits T cell-mediated autoimmune diseases and enhances Fas-mediated apoptosis through a protein kinase C-independent mechanism.
